Study sheds light on differences between male and female fat tissue, and health

October 23, 2018

TORONTO, October 23, 2018 - New research from York University on fat tissue is providing an important clue as to how females stay healthier than males, even as their body fat increases.

Published today in Frontiers in Physiology - Vascular Physiology, the research focusses on the differences between abdominal fat in obese male and female mice. A team of researchers under the direction of Professor Tara Haas found that the abdominal fat on female mice had more blood vessels than the fat on male mice, and that this protected the health of the female mice as they gained fat from eating a high-fat diet.

Males and females develop fat tissue differently and also differ in susceptibility to cardiovascular disease, insulin resistance and diabetes. However, the underlying biology behind why fat tissue in females is more protective against these conditions was not well understood, says Haas, a professor in the School of Kinesiology and Health Science, Faculty of Health.

Blood vessels are critical for maintaining healthy fat tissue by ensuring that the expanding fat cells are supplied with enough oxygen and nutrients, so the researchers looked at whether the abilities of the fat tissue to grow blood vessels and maintain healthy fat tissue would be different between males and females.

"We found that female mice have a higher number of blood vessels in their fat than males, and that females increase the number of blood vessels as they are fed a high fat diet, while males do not. We concluded that this response enabled females to maintain healthier fat and better insulin sensitivity," says Haas.

Martina Rudnicki, a York post-doctoral associate and first author of the study, pointed out that the study was unique because it focused on the differences in male and female fat tissue in the abdominal area. Although fat accumulates in different regions of the body, it is abdominal fat that is closely linked with increased risk of developing diabetes, particularly in males. So, the fact that females grow new blood vessels in this abdominal fat during weight gain may exert a health advantage for females.

The sex differences in the fundamental cellular processes that regulate the growth of blood vessels were unappreciated in the past, said Haas. It is important to understand them because they may contribute to an individual's susceptibility to develop serious obesity-related health complications such as diabetes, heart disease and cancer, ultimately impacting the health of more than 5.3 million Canadian adults.

The research team plans to confirm these findings in human samples. While it is clear that females also develop health problems with obesity, the fact that there was such a difference in the vascularization in male and female fat may mean it would be more effective to have different treatments for males and females.
-end-
Watch Professor Haas explain the findings in this video.

York University champions new ways of thinking that drive teaching and research excellence. Through cross-disciplinary programming, innovative course design, diverse experiential learning and a supportive community environment, our students receive the education they need to create big ideas that make an impact on the world. Located in Toronto, York is the third largest university in Canada, with a strong community of 53,000 students, 7,000 faculty and administrative staff, and more than 300,000 alumni.

York U's fully bilingual Glendon Campus is home to Southern Ontario's Centre of Excellence for French Language and Bilingual Postsecondary Education.

Media Contact:

Anjum Nayyar, York University Media Relations, 416-736-2100 ext. 44543, anayyar@yorku.ca

York University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.